Small molecule alpha(v) integrin antagonists: novel anticancer agents.


The members of the integrin family are targets that potentially provide both therapeutic and diagnostic opportunities. Advances in the understanding of the signalling pathways, transcriptional regulation and the structure/function relationships of the adhesion molecules to extracellular matrix proteins have all contributed to these opportunities. The role… (More)


  • Presentations referencing similar topics